2023
Effects on Patients of Continuous Eligibility for Medicaid Coverage: Lessons Learned and Lessons to Be Learned From the Pandemic
Churchwell K, O’Malley E. Effects on Patients of Continuous Eligibility for Medicaid Coverage: Lessons Learned and Lessons to Be Learned From the Pandemic. Circulation 2023, 147: e650-e652. PMID: 36877768, DOI: 10.1161/circulationaha.123.064067.Commentaries, Editorials and Letters
2013
Minimally invasive fibrillating mitral valve replacement for patients with advanced cardiomyopathy: A safe and effective approach to treat a complex problem
Brittain EL, Goyal SK, Sample MA, Leacche M, Absi TS, Papa F, Churchwell KB, Ball S, Byrne JG, Maltais S, Petracek MR, Mendes L. Minimally invasive fibrillating mitral valve replacement for patients with advanced cardiomyopathy: A safe and effective approach to treat a complex problem. Journal Of Thoracic And Cardiovascular Surgery 2013, 148: 2045-2051.e1. PMID: 24332110, PMCID: PMC4050032, DOI: 10.1016/j.jtcvs.2013.10.062.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiomyopathiesDisease-Free SurvivalFemaleHeart Valve Prosthesis ImplantationHospital MortalityHumansKaplan-Meier EstimateMaleMiddle AgedMinimally Invasive Surgical ProceduresMitral ValveMitral Valve InsufficiencyPostoperative ComplicationsRecurrenceRisk FactorsSeverity of Illness IndexStroke VolumeTime FactorsTreatment OutcomeVentricular Dysfunction, LeftVentricular Function, LeftVentricular Function, RightVentricular PressureVentricular RemodelingConceptsLV ejection fractionRecurrent mitral regurgitationRight ventricular systolic pressureVentricular systolic pressureMitral valve replacementSevere mitral regurgitationMitral regurgitationAdvanced cardiomyopathyValve replacementSystolic pressureLV dimensionsThoracic surgeonsNew York Heart Association classLV end-diastolic diameterComposite of deathEnd-diastolic diameterFirst postoperative visitOperative mortalityPostoperative morbidityPostoperative visitAssociation classClinical outcomesEjection fractionDevice insertionPatients
2012
MINIMALLY-INVASIVE MITRAL VALVE REPLACEMENT WITHOUT AORTIC CROSS-CLAMP IS SAFE IN PATIENTS WITH SEVERE CARDIOMYOPATHY
Brittain E, Goyal S, Leacche M, Absi T, Balaguer J, Churchwell K, Mendes L, Byrne J, Ball S, Petracek M. MINIMALLY-INVASIVE MITRAL VALVE REPLACEMENT WITHOUT AORTIC CROSS-CLAMP IS SAFE IN PATIENTS WITH SEVERE CARDIOMYOPATHY. Journal Of The American College Of Cardiology 2012, 59: e1996. DOI: 10.1016/s0735-1097(12)61997-4.Peer-Reviewed Original Research
2011
Acute Coronary Syndrome Pathways
Fong PP, Jackson EB, Churchwell KB, Steaban R, Starmer JM, Johnson DC, McNeil JD, Klint ZW, Scalf SL, Parsons CM, Cortez S, Christensen D, French T, McPherson JA. Acute Coronary Syndrome Pathways. Critical Pathways In Cardiology A Journal Of Evidence-Based Medicine 2011, 10: 1-8. PMID: 21562368, DOI: 10.1097/hpc.0b013e318211bb08.Commentaries, Editorials and LettersConceptsTreatment of ACSOutpatient care teamStandardization of careEvidence-based dataVanderbilt University Medical CenterComputerized provider order entry systemUniversity Medical CenterAcademic medical systemProvider order entry systemValue-based careOrder entry systemCare pathwayPatient outcomesCare teamComprehensive carePractice guidelinesMedical CenterPatientsCost of healthcareHealthcare expendituresReimbursement modelsSubstantial proportionCareSyndrome accountsACS
2005
Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
Stankewicz MA, Mansour CS, Eisner RL, Churchwell KB, Williams BR, Sigman SR, Streeter J, Patterson RE. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch. Journal Of Nuclear Medicine 2005, 46: 1602-9. PMID: 16204709.Peer-Reviewed Original ResearchConceptsMyocardial viabilityLeft ventriclePresence of severityEvidence of viabilityMyocardial viability assessmentNegative predictive valueViable myocardial tissueSurgical revascularizationCoronary diseaseClinical indicationsMetabolic assessmentSeverity criteriaAssessment of viabilityPET imagesPredictive valueWashout criteriaPatientsFDGQuantitative severityMyocardial tissuePositive criteriaGold standardWashoutSmall restingSeverity